621 related articles for article (PubMed ID: 21998005)
1. A generic, cross-chemical predictive PBTK model with multiple entry routes running as application in MS Excel; design of the model and comparison of predictions with experimental results.
Jongeneelen FJ; Berge WF
Ann Occup Hyg; 2011 Oct; 55(8):841-64. PubMed ID: 21998005
[TBL] [Abstract][Full Text] [Related]
2. Simulation of urinary excretion of 1-hydroxypyrene in various scenarios of exposure to polycyclic aromatic hydrocarbons with a generic, cross-chemical predictive PBTK-model.
Jongeneelen F; ten Berge W
Int Arch Occup Environ Health; 2012 Aug; 85(6):689-702. PubMed ID: 22038087
[TBL] [Abstract][Full Text] [Related]
3. A spreadsheet program for modeling quantitative structure-pharmacokinetic relationships for inhaled volatile organics in humans.
Béliveau M; Krishnan K
SAR QSAR Environ Res; 2005; 16(1-2):63-77. PubMed ID: 15844443
[TBL] [Abstract][Full Text] [Related]
4. Physiologically-based toxicokinetic modeling of durene (1,2,3,5-tetramethylbenzene) and isodurene (1,2,4,5-tetramethylbenzene) in humans.
Jałowiecki P; Janasik B
Int J Occup Med Environ Health; 2007; 20(2):155-65. PubMed ID: 17638682
[TBL] [Abstract][Full Text] [Related]
5. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
Liao KH; Tan YM; Clewell HJ
Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
[TBL] [Abstract][Full Text] [Related]
6. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
[TBL] [Abstract][Full Text] [Related]
7. A toxicokinetic model of malathion and its metabolites as a tool to assess human exposure and risk through measurements of urinary biomarkers.
Bouchard M; Gosselin NH; Brunet RC; Samuel O; Dumoulin MJ; Carrier G
Toxicol Sci; 2003 May; 73(1):182-94. PubMed ID: 12657741
[TBL] [Abstract][Full Text] [Related]
8. Development of physiologically based toxicokinetic models for improving the human indoor exposure assessment to water contaminants: trichloroethylene and trihalomethanes.
Haddad S; Tardif GC; Tardif R
J Toxicol Environ Health A; 2006 Dec; 69(23):2095-136. PubMed ID: 17060096
[TBL] [Abstract][Full Text] [Related]
9. PBTK modeling demonstrates contribution of dermal and inhalation exposure components to end-exhaled breath concentrations of naphthalene.
Kim D; Andersen ME; Chao YC; Egeghy PP; Rappaport SM; Nylander-French LA
Environ Health Perspect; 2007 Jun; 115(6):894-901. PubMed ID: 17589597
[TBL] [Abstract][Full Text] [Related]
10. A physiologically based pharmacokinetic model of organophosphate dermal absorption.
van der Merwe D; Brooks JD; Gehring R; Baynes RE; Monteiro-Riviere NA; Riviere JE
Toxicol Sci; 2006 Jan; 89(1):188-204. PubMed ID: 16221965
[TBL] [Abstract][Full Text] [Related]
11. [Specific nature of the software used to construct simulations: physiologically-based toxicokinetic models].
Jałowiecki P; Kostrzewski P
Med Pr; 2001; 52(5):361-8. PubMed ID: 11828851
[TBL] [Abstract][Full Text] [Related]
12. Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients.
Gajewska M; Worth A; Urani C; Briesen H; Schramm KW
Toxicol Lett; 2014 Jun; 227(3):189-202. PubMed ID: 24731971
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of semi-generic PBTK modeling for emergency risk assessment after acute inhalation exposure to volatile hazardous chemicals.
Olie JD; Bessems JG; Clewell HJ; Meulenbelt J; Hunault CC
Chemosphere; 2015 Aug; 132():47-55. PubMed ID: 25794648
[TBL] [Abstract][Full Text] [Related]
14. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
Aylward LL; Kirman CR; Blount BC; Hays SM
Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-property relationships for interspecies extrapolation of the inhalation pharmacokinetics of organic chemicals.
Béliveau M; Lipscomb J; Tardif R; Krishnan K
Chem Res Toxicol; 2005 Mar; 18(3):475-85. PubMed ID: 15777087
[TBL] [Abstract][Full Text] [Related]
16. A simple dermal absorption model: derivation and application.
ten Berge W
Chemosphere; 2009 Jun; 75(11):1440-5. PubMed ID: 19304310
[TBL] [Abstract][Full Text] [Related]
17. Comparison of indices proposed as criteria for assigning skin notation.
Lavoué J; Milon A; Droz PO
Ann Occup Hyg; 2008 Nov; 52(8):747-56. PubMed ID: 18687973
[TBL] [Abstract][Full Text] [Related]
18. In vitro dermal absorption rate testing of certain chemicals of interest to the Occupational Safety and Health Administration: summary and evaluation of USEPA's mandated testing.
Fasano WJ; McDougal JN
Regul Toxicol Pharmacol; 2008 Jul; 51(2):181-94. PubMed ID: 18501488
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of recommended REACH exposure modeling tools and near-field, far-field model in assessing occupational exposure to toluene from spray paint.
Hofstetter E; Spencer JW; Hiteshew K; Coutu M; Nealley M
Ann Occup Hyg; 2013 Mar; 57(2):210-20. PubMed ID: 23002273
[TBL] [Abstract][Full Text] [Related]
20. Refined PBPK model of aggregate exposure to methyl tertiary-butyl ether.
Kim D; Andersen ME; Pleil JD; Nylander-French LA; Prah JD
Toxicol Lett; 2007 Mar; 169(3):222-35. PubMed ID: 17336003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
